The pooled proportion of patients who experienced VA recurrence was 0.41 (95% CI 0.30 to 0.53, p=0.13). An increased risk of adverse outcomes during follow-up was observed in patients presenting with ...

Conclusion: Our results suggest that a high PVC burden and the presence of NSVT carry isolated prognostic value in CS. In addition, ventricular ectopy does not appear to be an indicator of disease ...

Limited studies have evaluated other arrhythmias in this population. Objective: We sought to assess the prevalence and significance of nonsustained ventricular tachycardia (NSVT) in pts who have had ...

These data suggest that VT rate and duration and other common clinical variables may not be sufficiently robust discriminators for the risk of syncope and hence, ICD design and programming.

Left ventricular hypertrophy (LVH) is an increase in the mass (weight) of the left ventricle, which is the heart's main pumping chamber. LVH develops either when the force or volume of blood within ...

Wolfe NK, Schiff MD, Christopher AB, et al., on behalf of FORCE Investigators. The study made use of the FORCE (Fontan Outcomes Registry Using CMR Examinations ...

AMIOVIRT: Amiodarone Versus Implantable Cardioverter–Defibrillator Trial; CABG-Patch: Coronary Artery Bypass Graft Patch Trial; CAT: Cardiomyopathy Trial; COMPANION: Comparison of Medical ...